NewsThursday, 27. September 2012
The results of a worldwide survey regarding the use of hypertonic saline (HS) solutions in CF therapy were presented at this year‘s ECFC conference in Dublin . The survey contains answers from approx. 200 physicians and data on over 10,000 of their patients (> 6 years) in Europe and the USA.
Tab.: The survey results by Agent et al. show that it is the 3-7% hypertonic saline solutions that are used most often amongst CF patients in Europe.
The study authors drew the following conclusions:
- 86.4% of CF physicians in Europe and the USA already use HS in the therapy of their patients.
- Among the hypertonic saline solutions, it is the 3-7% ones that are used most often in Europe.
- Most CF patients inhale HS twice a day.
Conclusion: This large survey has confirmed the wide dissemination of hypertonic saline solutions in CF therapy all over the world.
 Agent P et al. 2012 ECFC oral presentation 298